Home > Healthcare > Pharmaceuticals > Drug Delivery > Softgel Capsules Market
Softgel Capsules Market Size
Softgel Capsules Market size was worth over USD 8.9 billion in 2022. Driven by the rising prevalence of chronic disorders globally.
Chronic ailments such as cardiovascular diseases, cancer, and others have gained significant prominence. As per CDC, stroke is diagnosed in around 795,000 people every year in the U.S. alone, of which nearly 610,000 are new stroke cases. The rising disease burden and the subsequent surge in demand for advanced drug therapies will propel the demand for softgel capsules. Moreover, the growing number of ongoing clinical trials and novel product innovations will create ample growth opportunities for softgel capsules business.
| Report Attributes | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | USD 8.9 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 5.5% |
| 2032 Value Projection: | USD 15 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 200 |
| Tables, Charts & Figures: | 327 |
| Segments covered: | Type, Application, Manufacturer, Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
COVID-19 Impact
The COVID-19 pandemic asserted a positive impact on the softgel capsules market, driven by peak demand for vitamin and health supplements due to rising health awareness. As per NCBI, in March 2020, multivitamin sales witnessed a spike of 51.2% in the U.S., with total sales of vitamins and the associated supplements reaching around 120 million units during that period. However, favorable government support for the development of health supplements is further likely to present growth opportunities to the industry in the post-COVID-19 era as well.
Softgel Capsules Market Trends
Rising demand for plant-based capsules attributed to the surging awareness of sustainability, eco-friendliness, and preference for natural, vegetarian/vegan-friendly products will generate lucrative opportunities for market growth. Plant-based capsules are free from common allergens like dairy, gluten, and soy, making them a safer option for a broader range of people. Manufacturers are developing new plant-based materials that offer enhanced functionality and performance as capsule shells. Such innovations will further help strengthen the market outlook.
Softgel Capsules Market Analysis
Based on type, the gelatin-based softgel capsules market was valued at around USD 8 billion in 2022. Owing to their superior pH-dependent gelling and thermo-reversibility properties, gelatin-based capsules are easy to manufacture. They help improve the bioavailability of poorly water-soluble active ingredients, which contributes to the overall drug effectiveness. Additionally, they demonstrate excellent versatility, allowing manufacturers to customize the capsules based on shape, color, and other attributes, favoring their adoption through 2032.
Based on the manufacturer, the nutraceutical companies segment will surpass USD 6.8 billion by 2032. Surging incidences of osteoarthritis have augmented the demand for nutraceuticals made of herbs to counter the effects of inflammation. Growing health awareness has further bolstered the demand for nutraceutical supplements, supplementing segment growth. Furthermore, the increasing number of nutraceutical companies across the globe is creating a notable impetus for segment growth.
North America softgel capsules market size will reach over USD 3.9 billion by 2032. Surging prevalence of chronic disorders has increased the demand for softgel capsules in the region. The regional expansion can also be credited to growing healthcare expenditure, in line with the robust presence of leading softgel manufacturers such as Captek Softgel International Inc., Catalent Inc., and others. Moreover, growing health awareness has further bolstered the demand for health supplements in the region, supporting product uptake.
Softgel Capsules Market Share
- Catalent Inc.
- Aenova Group GmbH
- Procaps Group
- Patheon
- Estrellus
- Curtis Health Caps
- Sirio Pharma Co.
- Captek Softgel International Inc.
- Delpharm Evreux
Softgel Capsules Industry News:
- In March 2023, Lotus Pharmaceutical, a prominent pharmaceutical company, unveiled the Vietnamese launch of Vinorelbine soft gel capsules 80mg and 20mg. Presently, it is the first-ever Drug Authority of Vietnam-cleared generic Vinorelbine softgel.
- In August 2021, Catalent, Inc., a leading pharmaceutical company, announced its intent to acquire Bettera Holdings, LLC, a leader in the nutritional supplements space. This acquisition will help strengthen the company’s softgel portfolio while expanding its manufacturing capabilities.
This softgel capsules market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Type
- Gelatin based
- Vegetarian capsules
By Application
- Health & dietary supplements
- Vitamins
- Enzymes
- Omega 3
- Minerals
- Other health & dietary supplements
- Prescription medicine
- Antibiotics & antivirals
- Cough & cold drugs
- Other prescription medicines
By Manufacturer
- Pharmaceutical companies
- Nutraceutical companies
- Other manufacturers
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Frequently Asked Questions (FAQ) :